(Q52292819)

28 April 2018

title

Prognosticators for visual outcome in sarcoid uveitis. (English)

1 reference

28 April 2018

1 reference

Dana MR

1

1 reference

28 April 2018

Merayo-Lloves J

series ordinal

2

1 reference

28 April 2018

Schaumberg DA

series ordinal

3

1 reference

28 April 2018

Foster CS

series ordinal

4

1 reference

28 April 2018

publication date

1 November 1996

1 reference

28 April 2018

published in

Ophthalmology

1 reference

28 April 2018

volume

103

1 reference

28 April 2018

issue

11

1 reference

28 April 2018

page(s)

1846-1853

1 reference

28 April 2018

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

1 reference

7 January 2021

MANIFESTATIONS OF SARCOIDOSIS. ANALYSIS OF 145 PATIENTS, WITH A REVIEW OF NINE SERIES SELECTED FROM THE LITERATURE.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Course and prognosis of sarcoidosis around the world

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Ocular involvement in chronic sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Sarcoidosis and Its Ophthalmic Manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Conjunctival biopsy in the diagnosis of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Risk factors for ocular sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Epidemiology of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

THE EYES IN SARCOIDOSIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Course and outcome of ocular sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Fundus changes in histologically confirmed sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Sarcoidosis--a serious enigma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Disc edema, transient obscurations of vision, and a temporal fossa mass

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Sarcoidosis with optic nerve and retinal involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Laboratory diagnosis of ophthalmic sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Immunosuppressive drugs in immune and inflammatory ocular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

1 reference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

Uveitis and systemic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930417-X

7 January 2021

10.1016/S0161-6420(96)30417-X

Identifiers

DOI

1 reference

28 April 2018

1 reference

28 April 2018